News Bayer AG

Equities

Real-time Estimate Tradegate Other stock markets 03:36:38 2024-04-19 am EDT			5-day change	1st Jan Change
26.03 ^EUR	-0.79%		-2.99%	-22.21%

Apr. 18	Bayer’s Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation	MT
Apr. 18	Bayer: fast-track procedure in cardiology in the USA	CF

Bayer’s Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation	Apr. 18	MT
Bayer: fast-track procedure in cardiology in the USA	Apr. 18	CF
Study: US companies outpace Europe and Asia in research spending	Apr. 18	DP
Stifel Cuts Bayer PT, Keeps Hold Rating	Apr. 17	MT
Sat.1 to show top match between FC Bayern and Stuttgart	Apr. 17	DP
Conti slumps to early November level after figures	Apr. 17	DP
BAYER : Stifel lowers its target price	Apr. 17	CF
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Apr. 17	EQ
Bayer: presents results on Parkinson's disease	Apr. 16	CF
Bayer AG and Asklepios BioPharmaceutical, Inc Presents Results from the 18-Month Phase Ib Clinical Trial for AB-1005	Apr. 16	CI
Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains	Apr. 16	RE
Eurozone Industrial Production Recovery Boosts German Stocks Amid Growing Tensions in Middle East	Apr. 15	MT
UBS Trims Bayer PT, Maintains Neutral Rating	Apr. 15	MT
BAYER AG : Barclays reaffirms its Neutral rating	Apr. 15	ZD
Nutrien Plans Exit From Argentina, Chile	Apr. 15	MT
BAYER : UBS lowers price target	Apr. 15	CF
BAYER AG : Gets a Neutral rating from JP Morgan	Apr. 15	ZD
BAYER : Another peer group tidy up	Apr. 14
Bayer's patent for blood thinner Xarelto invalid, UK court rules	Apr. 12	RE
BAYER AG : UBS sticks Neutral	Apr. 12	ZD

No results for this search

BAYER : Another peer group tidy up

April 14, 2024 at 03:26 pm EDT

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am EST